Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annachiara Esposito
Observed names:
A. Esposito,
Esposito, Annachiara
Institution:
Università Cattolica del Sacro Cuore
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
Istituti di Ricovero e Cura a Carattere Scientifico,
University of Naples Federico II
ORCID:
0000-0002-5017-1954
Observed ORCID:
0000-0002-5017-1954
OpenAlex ID:
A5084544712
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
2019
·
Margherita Passariello
, Anna Morena D’Alise
, et al.
·
Scientific Reports
·
58
PDF
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
2024
·
A. Esposito
, A. Agostini
, et al.
·
Cell Death and Disease
·
44
PDF
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
2022
·
Geny Piro
, Carmine Carbone
, et al.
·
British Journal of Cancer
·
38
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms
2024
·
Antonio Agostini
, Geny Piro
, et al.
·
Nature Communications
·
30
PDF
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
2021
·
Geny Piro
, Antonio Agostini
, et al.
·
Frontiers in Medicine
·
23
PDF
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
2020
·
Vincenzo Nasca
, Marta Chiaravalli
, et al.
·
International Journal of Molecular Sciences
·
22
PDF
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
2023
·
Antonio Agostini
, Ilaria Guerriero
, et al.
·
Journal of Translational Medicine
·
15
PDF
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
2025
·
Carmine Carbone
, Roberto De Luca
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
12
PDF
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer
2026
·
Alessia Caggiano
, Antonio Agostini
, et al.
·
癌症:英文版
·
1
PDF
Transcriptomic dissection of Intraepithelial Papillary Mucinous Neoplasms progression by spatial technologies identified novel markers of pancreatic carcinogenesis
2022
·
Antonio Agostini
, Geny Piro
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Spatial transcriptomics identified mucin-specific O-glycosylation as a key pathway in pancreatic cancer development and a promising therapeutic target
2022
·
Antonio Agostini
, Ilaria Guerriero
, et al.
·
Research Square
PDF
The role of CXCR1/2 dual inhibitor ladarixin on tumor burden and immunotherapy response in pancreatic cancer.
2022
·
Giampaolo Tortora
, Geny Piro
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
28
Citation count:
245
H-index:
8
I10-index:
8
Year
Topic
Type